Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells ; volume:9 ; number:1 ; day:10 ; month:8 ; year:2018 ; pages:1-14 ; date:12.2018
Nature Communications ; 9, Heft 1 (10.8.2018), 1-14, 12.2018

Creator: Wu, Changjie

Contributor: Lyu, Junfang
Yang, Eun Ju
Liu, Yifan
Zhang, Baoyuan
Shim, Joong Sup
SpringerLink (Online service)

DOI: 10.1038/s41467-018-05694-4

URN: urn:nbn:de:101:1-2018102401254957388491

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wu, Changjie
Lyu, Junfang
Yang, Eun Ju
Liu, Yifan
Zhang, Baoyuan
Shim, Joong Sup
SpringerLink (Online service)

Other Objects (12)

Modeling synthetic lethality

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

Epigenetic synthetic lethality approaches in cancer therapy

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Advances in synthetic lethality modalities for glioblastoma multiforme

High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Hochschulschrift

Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Synthetic lethality in lung cancer and translation to clinical therapies

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Modeling synthetic lethality

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

Epigenetic synthetic lethality approaches in cancer therapy

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Advances in synthetic lethality modalities for glioblastoma multiforme

High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Hochschulschrift

Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Synthetic lethality in lung cancer and translation to clinical therapies

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Modeling synthetic lethality

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

Epigenetic synthetic lethality approaches in cancer therapy

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Advances in synthetic lethality modalities for glioblastoma multiforme

High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Hochschulschrift

Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Synthetic lethality in lung cancer and translation to clinical therapies

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Modeling synthetic lethality

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

Epigenetic synthetic lethality approaches in cancer therapy

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Advances in synthetic lethality modalities for glioblastoma multiforme

High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Synthetic lethality in lung cancer and translation to clinical therapies

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Modeling synthetic lethality

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

Epigenetic synthetic lethality approaches in cancer therapy

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Advances in synthetic lethality modalities for glioblastoma multiforme

High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Synthetic lethality in lung cancer and translation to clinical therapies

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Modeling synthetic lethality

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

Epigenetic synthetic lethality approaches in cancer therapy

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Advances in synthetic lethality modalities for glioblastoma multiforme

High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Synthetic lethality in lung cancer and translation to clinical therapies

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Related objects

Reset password